UCREST | UCREST BHD [NS]

8 8
0.075 (7.14%)

T-O (am): 0.000 (08:59:00)
Last updated: 11:54

Fundamental
Technical
Total Score

UCREST | UCREST BHD

UCREST [NS] Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

UCREST [NS] Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
29 Oct 25 Q1 Aug 2025 1 31 May 2026 3.31 1.11 1.11 33.6% 0.00 0.15 29.0% 25.1% 33.2% 143.3%
29 Jul 25 Q4 May 2025 4 31 May 2025 4.66 1.66 1.66 35.7% 0.00 0.22 28.4% 1.9% 0.7% 104.4%
29 Apr 25 Q3 Feb 2025 3 31 May 2025 6.51 1.65 1.65 25.4% 0.00 0.22 41.1% 12.4% 18.7% 14.2%
22 Jan 25 Q2 Nov 2024 2 31 May 2025 4.62 1.39 1.39 30.2% 0.00 0.19 74.5% 11.8% 204.8% 11.9%
29 Oct 24 Q1 Aug 2024 1 31 May 2025 2.65 0.46 0.46 17.3% 0.00 0.06 42.1% 32.8% 43.9% 51.4%
30 Jul 24 Q4 May 2024 4 31 May 2024 4.57 0.81 0.81 17.8% 0.00 0.11 21.1% 26.3% 57.8% 59.4%
26 Apr 24 Q3 Feb 2024 3 31 May 2024 5.79 1.93 1.93 33.2% 0.00 0.26 40.4% 15.7% 54.8% 11.5%
30 Jan 24 Q2 Nov 2023 2 31 May 2024 4.13 1.25 1.25 30.2% 0.00 0.17 107.2% 208.3% 32.5% 140.9%
26 Oct 23 Q1 Aug 2023 1 31 May 2024 1.99 0.94 0.94 47.2% 0.00 0.13 67.9% 88.8% 53.1% 190.8%
26 Jul 23 Q4 May 2023 4 31 May 2023 6.21 2.00 2.00 32.3% 0.00 0.29 23.9% 468.9% 8.0% 107.3%
28 Apr 23 Q3 Feb 2023 3 31 May 2023 5.01 2.18 2.18 43.5% 0.00 0.31 274.1% 360.8% 171.5% 152.8%
19 Jan 23 Q2 Nov 2022 2 31 May 2023 1.34 -3.04 -3.04 -227.3% 0.00 -0.49 26.9% 55.5% 194.0% 4.9%
28 Oct 22 Q1 Aug 2022 1 31 May 2023 1.05 -1.03 -1.03 -98.1% 0.00 -0.17 3.3% 85.0% 96.2% 388.2%
29 Jul 22 Q4 May 2022 4 31 May 2022 1.09 -27.56 -27.56 -2526.4% 0.00 -4.43 0.4% 65.4% 568.0% 610.5%
27 Apr 22 Q3 Feb 2022 3 31 May 2022 1.09 -4.13 -4.13 -379.6% 0.00 -0.66 63.9% 92.8% 28.9% 295.3%
27 Jan 22 Q2 Nov 2021 2 31 May 2022 3.01 -3.20 -3.20 -106.2% 0.00 -0.51 57.2% 17.1% 1409.4% 222.5%
29 Oct 21 Q1 Aug 2021 1 31 May 2022 7.04 -0.21 -0.21 -3.0% 0.00 -0.03 123.4% 114.9% 103.9% 117.8%
13 Aug 21 Q4 May 2021 4 31 May 2021 3.15 5.40 5.40 171.4% 0.00 0.87 79.1% 0.0 155.5% 155.6%
28 Apr 21 Q3 Feb 2021 3 31 May 2021 15.05 2.23 2.11 14.0% 0.00 0.37 314.4% 560.0% 19.1% 176.3%
29 Jan 21 Q2 Nov 2020 2 31 May 2021 3.63 2.61 2.61 72.0% 0.00 0.52 10.9% 44.8% 119.2% 295.7%
26 Oct 20 Q1 Aug 2020 1 31 May 2021 3.27 1.19 1.19 36.4% 0.00 0.25 0.0 56.4% 112.3% 733.6%
10 Aug 20 Q4 May 2020 4 31 May 2020 0.00 -11.88 -9.71 0.0% 0.00 -2.09 100.0% 100.0% 250.8% 268.9%
19 Jun 20 Q3 Feb 2020 3 31 May 2020 2.28 -2.77 -2.77 -121.4% 0.00 -0.60 9.1% 68.3% 107.3% 213.0%
22 Jan 20 Q2 Nov 2019 2 31 May 2020 2.51 -1.33 -1.33 -53.2% 0.00 -0.29 66.6% 76.4% 1033.6% 143.4%
23 Oct 19 Q1 Aug 2019 1 31 May 2020 7.51 0.14 0.14 1.9% 0.00 0.03 157.6% 55.4% 105.4% 96.5%
31 Jul 19 Q4 May 2019 4 31 May 2019 2.92 -3.46 -2.63 -90.2% 0.00 -0.57 59.5% 76.3% 207.4% 174.7%
29 Apr 19 Q3 Feb 2019 3 31 May 2019 7.20 3.06 2.45 34.0% 0.00 0.53 32.2% 36.0% 20.4% 31.8%
29 Jan 19 Q2 Nov 2018 2 31 May 2019 10.62 2.61 3.08 29.0% 0.00 0.66 37.0% 35.5% 23.8% 1.6%
30 Jul 18 Q4 May 2018 4 31 May 2018 16.86 4.00 4.04 24.0% 0.00 1.09 36.7% 243.2% 14.7% 508.3%
25 Apr 18 Q3 Feb 2018 3 31 May 2018 12.33 3.57 3.52 28.6% 0.00 0.84 9.7% 2275.7% 2.0% 980.5%
22 Jan 18 Q2 Nov 2017 2 31 May 2018 11.24 4.32 3.59 32.0% 0.00 1.06 43.4% 18324.6% 18.7% 753.5%
19 Oct 17 Q1 Aug 2017 1 31 May 2018 7.84 3.69 3.03 38.6% 0.00 0.95 59.5% 3429.7% 355.9% 686.6%
08 Aug 17 Q4 May 2017 4 31 May 2017 4.91 0.67 0.66 13.5% 0.00 0.21 846.4% 0.0 266.0% 224.6%
25 Apr 17 Q3 Feb 2017 3 31 May 2017 0.52 -0.40 -0.40 -77.1% 0.00 -0.13 750.8% 60.5% 27.3% 184.8%
26 Jan 17 Q2 Nov 2016 2 31 May 2017 0.06 -0.55 -0.55 -901.6% 0.00 -0.17 72.5% 94.3% 6.6% 280.9%
04 Oct 16 Q1 Aug 2016 1 31 May 2017 0.22 -0.52 -0.52 -232.4% 0.00 -0.16 0.0 71.3% 3.2% 5.3%
27 Jul 16 31 May 2016 Other 31 May 2016 0.00 -0.46 -0.53 0.0% 0.00 -0.17 100.0% 100.0% 212.9% 117.4%
24 May 16 31 Mar 2016 Other 31 May 2016 1.31 0.47 0.47 36.0% 0.00 0.16 22.9% 382.7% 55.3% 173.9%
25 Feb 16 31 Dec 2015 Other 31 May 2016 1.07 0.30 0.30 28.5% 0.00 0.10 38.2% 9.9% 155.8% 106.3%
25 Nov 15 30 Sep 2015 Other 31 May 2016 0.77 -0.55 -0.55 -70.5% 0.00 -0.19 294.4% 1832.5% 117.8% 34.0%
20 Aug 15 Q2 Jun 2015 2 31 Dec 2015 0.20 3.06 3.06 1563.8% 0.00 1.05 27.9% 17.4% 579.7% 629.4%
20 May 15 Q1 Mar 2015 1 31 Dec 2015 0.27 -0.64 -0.64 -234.9% 0.00 -0.22 72.0% 138.6% 86.8% 12.5%
25 Feb 15 31/12/14 4 31/12/14 0.97 -5.19 -4.83 -496.6% 0.00 -1.66 2330.0% 56.4% 484.4% 553.7%

UCREST [NS] Historical Dividends

UCREST [NS] Financial Ratios

EPS 0.78 sen
Trailing PE (Sector Median: 21.9) 9.4
PEG 0.09
Altman Z 1.1
Beaver -0.495
Current Ratio 6.2
Debt-Equity (DE) Ratio 0.11
FCF Yield -4.46 %
Revenue QoQ -29.0 %
Revenue YoY 25.09%
Profit QoQ -33.17 %
Profit YoY 143.33 %
Profit Margin (Sector Median: 2.8) 30.48 %
ROE (ROIC: 12.88) 12.88 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

UCREST [NS] Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 21.9)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 2.8)
ROE (ROIC: -1.92)
Altman Z

UCREST [NS] Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.06
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] -0.49
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

UCREST [NS] Directors Share Purchases (Beta)


ENCIK ABDUL RAZAK BIN DATO' HAJI IPAP reduced 1000000.0 units announced on 28 Feb 2022 at ~RM0.235

ENCIK ABDUL RAZAK B DATO’ HAJI IPAP reduced 1000000.0 units announced on 29 Oct 2021 at ~RM0.235

MR THONG KOOI PIN reduced 500000.0 units announced on 01 Oct 2021 at ~RM0.265

ENCIK ABDUL RAZAK BIN DATO' HAJI IPAP reduced 500000.0 units announced on 08 Jul 2021 at ~RM0.3

THONG KOOI PIN reduced 500000.0 units announced on 25 Jun 2021 at ~RM0.31

MADAM CHUAN TSUI JU reduced 500000.0 units announced on 25 May 2021 at ~RM0.345

UCREST [NS] Summary


Market Cap: 55 M.

Market Cap Class: Shrimp

Number of Shares: 743 M.

Adjusted Float: 88.0%.

Stock highly correlated with

HEXCAP (92%)

KEYASIC (92%)

ARBB (90%)

SWSCAP (89%)

UCrest Berhad is an investment company and through its subsidiaries, the company is principally involved in information technology-related products and services. The company is a provider of advanced cloud hospitals and mobile health services. It also provides the iMedic application, which helps people with chronic conditions and other health conditions who may need to track daily health metrics such as blood pressure, glucose, oxygen saturation and more. UCrest Berhad was incorporated in 1997 and is based in Petaling Jaya, Malaysia.

Sectors: Technology Equipment, Penny Stocks, Vaccine, Technology

Code: 0005

Website: https://www.ucrest.net

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

UCREST [NS] Top Shareholdings

Updated on 1-Sep-2023

Shareholder % Value (M)
Eg Kah Yee 12.03% 6.71
Ng Geok Lui 4.39% 2.45
United Crest Equity Ltd 3.88% 2.17
Liew Wai Han 3.67% 2.05
Lim Lae Yong 3.39% 1.89
Leong Mei Choon 3.31% 1.85
Ng Wen Xian Jessica 2.7% 1.51
Li Qinghong 2.69% 1.5
Lee Kin Hin 2.58% 1.44
Phillip Securities Pte. Ltd. 1.59% 0.89
See Lee Ming 1.48% 0.83
Loo Saw Eng 0.96% 0.53
Hong Mun Kun 0.67% 0.37
Carolyn Wong Tarnn Yoong 0.61% 0.34
BOCI Securities Ltd 0.57% 0.32
Liew See Kim 0.54% 0.3
Leow Wee Cheng 0.52% 0.29
Victor Chai Cheng Wah 0.46% 0.25
Canvas Technology Pte Ltd 0.35% 0.2
Teh Boon King 0.33% 0.18
Teo Hur Tean 0.29% 0.16
Liew Thau Sen 0.27% 0.15
Eg Kaa Chee 0.27% 0.15
Neoh Ang Hing 0.27% 0.15
Mohd Fikri Bin Abdullah 0.27% 0.15
Anthony Lee Cheng Teik 0.24% 0.14
Goh Gaik Suan 0.23% 0.13
Frequently Asked Questions
UCrest Berhad is an investment company and through its subsidiaries, the company is principally involved in information technology-related products and services. The company is a provider of advanced cloud hospitals and mobile health services. It also provides the iMedic application, which helps people with chronic conditions and other health conditions who may need to track daily health metrics such as blood pressure, glucose, oxygen saturation and more. UCrest Berhad was incorporated in 1997 and is based in Petaling Jaya, Malaysia. The company is listed on Bursa Malaysia and operates in the Technology Equipment, Penny Stocks, Vaccine and Technology sectors.
No, UCREST BHD is not Shariah-compliant.
The latest share price of UCREST BHD is RM 0.075 updated on 23 January 2026 11:54.
As of now, UCREST BHD has a market capitalization of 55M based on the latest financial data.
iSaham's technical analysis indicates that UCREST BHD's support level is at RM 0.075 and its resistance level is at RM 0.075, based on moving averages and price patterns.
The 52-week high for UCREST BHD is RM 0.075
UCREST BHD's share price has decreased by -25.0% year-to-date, influenced by market trends and company performance.
Dividend information for UCREST BHD has not been reported yet. Track UCREST BHD's upcoming dividend announcements, yield changes, and payout history easily with the iSaham Stock Screener.
The main shareholders of UCREST BHD include Eg Kah Yee, Ng Geok Lui and United Crest Equity Ltd. View more on UCREST BHD Top Shareholders page.
You can buy UCREST BHD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.